Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diacetylrhein, an anthraquinone antiarthritic agent, suppresses dextran sodium sulfate-induced inflammation in rats: A possible mechanism for a protective effect against ulcerative colitis.
Zohny MH, Alrouji M, Alhajlah S, AlOmeir O, Ewees MGE, Ghaffar DMA, El Adle Khalaf N, Mohammed OA, Abdeldaiem MSI, El-Bahouty WB, Elrabat A, Zakaria S, Abdel-Nasser ZM, Haleem AA, El-Gharbawy DM, Abdelhady R, Kaddah MMY, Shata A, Saber S. Zohny MH, et al. Among authors: alrouji m. Biomed Pharmacother. 2022 Oct;154:113651. doi: 10.1016/j.biopha.2022.113651. Epub 2022 Sep 5. Biomed Pharmacother. 2022. PMID: 36081290 Free article.
Host Immune Responses to Salivary Components - A Critical Facet of Tick-Host Interactions.
Ali A, Zeb I, Alouffi A, Zahid H, Almutairi MM, Ayed Alshammari F, Alrouji M, Termignoni C, Vaz IDS Jr, Tanaka T. Ali A, et al. Among authors: alrouji m. Front Cell Infect Microbiol. 2022 Mar 16;12:809052. doi: 10.3389/fcimb.2022.809052. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35372098 Free PMC article. Review.
Linagliptin and Empagliflozin Inhibit Microtubule Affinity Regulatory Kinase 4: Repurposing Anti-Diabetic Drugs in Neurodegenerative Disorders Using In Silico and In Vitro Approaches.
Atiya A, Das Gupta D, Alsayari A, Alrouji M, Alotaibi A, Sharaf SE, Abdulmonem WA, Alorfi NM, Abdullah KM, Shamsi A. Atiya A, et al. Among authors: alrouji m. ACS Omega. 2023 Feb 7;8(7):6423-6430. doi: 10.1021/acsomega.2c06634. eCollection 2023 Feb 21. ACS Omega. 2023. PMID: 36844587 Free PMC article.
Anti-tubercular activity evaluation of natural compounds by targeting Mycobacterium tuberculosis resuscitation promoting factor B inhibition: An in silico study.
Rabaan AA, Garout M, Aljeldah M, Al Shammari BR, Alawfi A, Alshengeti A, Najim MA, Alrouji M, Almuhanna Y, Alissa M, Mashraqi MM, Alwashmi ASS, Alhajri M, Alateah SM, Farahat RA, Mohapatra RK. Rabaan AA, et al. Among authors: alrouji m. Mol Divers. 2023 Mar 24. doi: 10.1007/s11030-023-10632-8. Online ahead of print. Mol Divers. 2023. PMID: 36964456
Corrigendum to "PF543-like compound, a promising sphingosine kinase 1 inhibitor: Structure-based virtual screening and molecular dynamic simulation approaches" [Int. J. Biol. Macromol. 245 (2023) 125466].
Shahwan M, Hassan N, Ashames A, Alrouji M, Alhumaydhi F, Al Abdulmonem W, Muhsinah AB, Furkan M, Khan RH, Shamsi A, Atiya A. Shahwan M, et al. Among authors: alrouji m. Int J Biol Macromol. 2023 Sep 1;248:126399. doi: 10.1016/j.ijbiomac.2023.126399. Epub 2023 Aug 26. Int J Biol Macromol. 2023. PMID: 37640617 No abstract available.
Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosis.
El-Kashef DH, Youssef ME, Nasr M, Alrouji M, Alhajlah S, AlOmeir O, El Adle Khalaf N, Ghaffar DMA, Jamil L, Abdel-Nasser ZM, Ibrahim S, Abdeldaiem MSI, Donia SS, Mohammed OA, Morsy NE, Shata A, Saber S. El-Kashef DH, et al. Among authors: alrouji m. Biomed Pharmacother. 2022 Sep;153:113487. doi: 10.1016/j.biopha.2022.113487. Epub 2022 Jul 31. Biomed Pharmacother. 2022. PMID: 36076505 Free article.
The level of public awareness of cancer in Hail, Saudi Arabia.
Alsaedi A, Alrashidy AM, Alodaily SF, Alomeir O, Alrouji M, Alhajlah S. Alsaedi A, et al. Among authors: alrouji m. Eur Rev Med Pharmacol Sci. 2022 Oct;26(19):7063-7069. doi: 10.26355/eurrev_202210_29891. Eur Rev Med Pharmacol Sci. 2022. PMID: 36263554 Free article.
Chitosan modified 5-fluorouracil nanostructured lipid carriers for treatment of diabetic retinopathy in rats: A new dimension to an anticancer drug.
Sharma DS, Wadhwa S, Gulati M, Kumar B, Chitranshi N, Gupta VK, Alrouji M, Alhajlah S, AlOmeir O, Vishwas S, Khursheed R, Saini S, Kumar A, Parveen SR, Gupta G, Zacconi F, Chellappan DK, Morris A, Loebenberg R, Dua K, Singh SK. Sharma DS, et al. Among authors: alrouji m. Int J Biol Macromol. 2023 Jan 1;224:810-830. doi: 10.1016/j.ijbiomac.2022.10.168. Epub 2022 Oct 24. Int J Biol Macromol. 2023. PMID: 36302483
Secondary Metabolite Profiling, Antioxidant, Antidiabetic and Neuroprotective Activity of Cestrum nocturnum (Night Scented-Jasmine): Use of In Vitro and In Silico Approach in Determining the Potential Bioactive Compound.
Ahmad S, Alrouji M, Alhajlah S, Alomeir O, Pandey RP, Ashraf MS, Ahmad S, Khan S. Ahmad S, et al. Among authors: alrouji m. Plants (Basel). 2023 Mar 7;12(6):1206. doi: 10.3390/plants12061206. Plants (Basel). 2023. PMID: 36986895 Free PMC article.
45 results